Transitioning Patients to Newer Therapy with Financial Support Awareness

See how OptimizeRx delivered 3,000 new prescriptions by increasing provider awareness of a brand’s financial support program

3000-incremental-prescriptions

CLIENT GOAL

A respiratory brand team needed to seamlessly transition patients to a newer version of their therapy, while keeping medication affordable.

  • 443% Return on investment
  • 3,000 Incremental new prescriptions, a 58% increase among targeted providers
  • 51% Targeted providers prescribing the therapy

THE CHALLENGE

  • New drug delivery mechanism offered benefits over prior version, but medication cost was a potential disincentive to switching.
  • Patient population highly at risk from COVID-19, and susceptible to economic difficulties or job/insurance loss due to the pandemic.
  • Competitive treatment landscape, with multiple alternative therapies available.

Download full case study

HOW WE DID IT

Targeted HCP awareness campaign that raised brand visibility among providers directly within the EHR, while increasing transparency around drug cost and financial assistance available to patients.

point-of-care-prescribe-engagement-icon
Point-Of-Prescribe Engagement

Positioned brand and available savings offer directly in patient charts, so providers could easily identify qualified patients and discuss medication costs.

improving-medication-access-icon
Improving Medication Access

Simplified participation in financial assistance program by relaying coupon information directly to pharmacies and patients, reducing out-of-pocket cost.

extensive-provider-reach-icon
Extensive Provider Reach

Provided access to providers across 300+ EHRs and ePrescribe platforms, covering 60% of ambulatory HCPs in the US market.

Learn how increasing provider awareness of financial support programs reduces medication cost barriers and drives prescription volume

TALK TO OUR TEAM TODAY